A detailed history of Scientech Research LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 18,727 shares of RLAY stock, worth $79,215. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,727
Holding current value
$79,215
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.23 - $9.51 $116,669 - $178,093
18,727 New
18,727 $133 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.